Fundraising FoxLensar
NASDAQ: LNSROrlando, US · Delaware corporation · 2 known investors
Find your way into Lensar
Sign up to see every warm intro you have to Lensar
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lensar team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lensar designs and markets laser systems for cataract surgery and corneal astigmatism correction, offering products that incorporate imaging and precision-guidance technologies to help surgeons achieve consistent visual outcomes.
Founders & leadership
RW
Randy W FreyFounder
AR
Amy R BrooksExecutive
PJ
Peter J MarianiExecutive
KH
Keith H EdwardsExecutive
RD
Ronald D GoldrichExecutive
Board
CL
Carmen L BringgoldBoard director
JH
SA
LK
Lothar KoobBoard director
CW
Charles W FedericoBoard director
Investors · 2
Aisling Capitallisted by Aisling CapitalNew Yorkvia Steven Elms · board
How we know: Aisling Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$70M disclosed across 4 rounds · 2012–2023
▶$20MraisedMay 2023 · 1 investors · Other Health CareRule 506(b)
▶$20MraisedMay 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gary M. WinerDirector
- Richard L. LindstromDirector
- Thomas R. Staab, IIExecutive Officer
- Aimee S. WeisnerDirector
- Alan B. ConnaughtonExecutive Officer
- Elizabeth G. O'FarrellDirector
- William J. LinkDirector
- Nicholas T. CurtisExecutive Officer, Director
- John P. McLaughlinDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedJan 2015 · 2 investors · Other Health CareRule 506(b)
▶$16MraisedJan 2015 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lothar KoobDirector
- Alan B ConnaughtonExecutive Officer
- Amy R BrooksExecutive Officer
- Charles W FedericoDirector
- Carmen L BringgoldDirector
- Peter J MarianiExecutive Officer
- Nicholas T CurtisExecutive Officer, Director
- Josh H BilenkerDirector
- Steven A ElmsDirector
- Offering amount
- $20M
- Amount sold
- $16M
- Proceeds to insiders
- $645K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedJan 2014 · 14 investors · Other Health CareRule 506(b)
▶$10MraisedJan 2014 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven A ElmsDirector
- Amy R BrooksExecutive Officer
- Josh H BilenkerDirector
- Nicholas T CurtisExecutive Officer, Director
- Randy W FreyDirector
- Lothar KoobExecutive Officer, Director
- Alan B ConnaughtonExecutive Officer
- Keith H EdwardsExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- Proceeds to insiders
- $370K
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24MraisedMar 2012 · 2 investors · Other Health CareRule 506(b)
▶$24MraisedMar 2012 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas T CurtisExecutive Officer
- Alan B ConnaughtonExecutive Officer
- Josh H BilenkerDirector
- Amy R BrooksExecutive Officer
- Steven A ElmsDirector
- Randy W FreyDirector
- Keith H EdwardsExecutive Officer
- Ronald D GoldrichExecutive Officer
- Lothar KoobExecutive Officer, Director
- Offering amount
- $24M
- Amount sold
- $24M
- Proceeds to insiders
- $2M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
AlconAlcon is a global eye care company that develops and manufactures ophthalmologic products and surgical systems to improve vision. The company serves patients, surgeons, and underserved communities worldwide through product innovation, surgeon training programs, and vision screening initiatives.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
AlconAlcon develops eye care products and medical technologies, including the Valeda Photobiomodulation (PBM) system for retina treatment, for eye care professionals such as retina specialists.
Companies working in the same space as Lensar.
Frequently asked questions
- What does Lensar do?
- Lensar designs and markets laser systems for cataract surgery and corneal astigmatism correction, offering products that incorporate imaging and precision-guidance technologies to help surgeons achieve consistent visual outcomes.
- Who founded Lensar?
- Lensar was founded by Randy W Frey.
- Who are Lensar's investors?
- Lensar's investors include Aisling Capital, Versant Venture AIV Holdings.
- How much funding has Lensar raised?
- Lensar has disclosed $70M raised across 4 rounds.
- Where is Lensar headquartered?
- Lensar is headquartered in Orlando, US.